UK medical cannabis market seen reaching 140,000 patients by 2026

Newsweed projects UK medical cannabis patient base will exceed 140,000 by year-end, as operators expand manufacturing and distribution.

FILE — harvest · My 420 Tours / CC BY-SA 4.0

The UK medical cannabis market is projected to exceed 140,000 patients by 2026, according to reporting from Newsweed. The figure suggests continued growth in a market that remains tightly regulated but increasingly competitive, with multiple operators moving to establish production capacity and supply agreements.

Recent weeks have seen significant infrastructure investment: Curaleaf Laboratories began manufacturing medical cannabis suppositories in May, while SOMAÍ and Seed Junky Genetics have pursued UK brand and distribution partnerships. Aurora Cannabis acquired Safari Flower Co. for $26.5 million in April, signaling confidence in the market's trajectory. These moves indicate suppliers are positioning for scaled patient enrollment.

Watch whether the 140,000-patient projection materializes and how quickly prescriber adoption accelerates. Supply-side growth appears outpacing historical patient-access trends, suggesting margins may depend on physician confidence and NHS integration moving forward.